Strategic Management and Sustainability

2 Strategic Management and
Sustainability

TABLE OF CONTENT
INTRODUCTION.................................................................................................................................3
MAIN BODY........................................................................................................................................3
Key business strategies within past 5 years.......................................................................................3
Resources and capabilities of company used within company...........................................................5
Evaluating how AstraZeneca can implement environmental sustainability theories, science and
ways of thinking to become more competitive..................................................................................7
CONCLUSION.....................................................................................................................................9
REFERENCES....................................................................................................................................11

INTRODUCTION
Management refer to set of actions, strategies, practices and activities that help to
achieve strategic goals and objectives of companies. While sustainability is defined as a
capacity of a company to endure in relatively ongoing way across several domains. The
current study will be based on AstraZeneca, which falls under category of leading British
multinational pharmaceutical organizations. The current assignment will explain key venture
tactics of company over the past five years, for which relevant framework will use that
discuss why this strategy was changed or pursued. It will justify capabilities and resources of
case study firm over the past five years and define to what extent it has aligned its assets and
strengths to its venture tactics. Furthermore, lastly the report will clarify how chosen
enterprise can implement environmental sustainability ways, theories and science of thinking
to become more competitive.
MAIN BODY
Key business strategies within past 5 years
Astra Zeneca is known as one of the biggest pharmaceutical company within global
domains which has been transforming best technology innovation s in all medicines for
growth and strong diversified commercial execution. The company focuses functionally
towards innovation and delivery of pharmaceutical services within society around world, for
high scale functional efficiency standards. Astra Zeneca fundamental strategy are clear,
where it heads specific focus on innovative science and leaderships within main therapy areas
based on oncology, cardiovascular, renal and metabolism and varied range of respiratory
diseases (The pharma industry trends from 2020 that form our marketing predictions for
2021, 2021).During the last strategies within 5 years delivery of innovation within life
changing medicines has contributed value to patients around world. Strategies are based on
burden of disease increasing large parameters of fundamental growth, innovation being more
patient centric and employing best technology parameters.
Framework such as swot analysis, internal business environment scanning will enable
functional growth analysis towards wide range advancement. Stronger vision oriented aspects
and new innovative resource planning evolving within company has been specifically

growing, at Astra Xeneca for bringing new scale work advancement heading towards best
targets.
 Strengths: Astra Zeneca offers best quality pharmaceutical drugs and productive
medical services, where company has been heading towards structural innovation and
also to evolve on stronger range of competencies. Company has been leading in
expertise within drug production in recent years, where vaccine of Covid-19 by firm
is much awaited which has potentially created strong brand value.
 Weakness: High rise in prices of drugs and new competitive domains have strong
impact on bringing new rise towards higher cost factor, where rise on prices in drugs
have lowered business new competencies.
 Opportunities: There is opportunity to expand new research centres, pharmacy
services within global aspects under world with new expanded resource planning
aspects and to bring on best determinants.
 Threats: The Company also faces threat from higher development cost within
business scale, where external factors of business environment have strong impact
towards evolving new range of determinants. Threat of external business synergies,
with external fluctuating economies has strong impact towards potential benchmarks
and for bringing new scale capital expansion.
AstraZeneca has improved strong range of pharmaceutical productive services in
evolving continuous procedures where biological and innovation activities, within biological
labs have enabled research in new medicines successful. The company in recent 5 years have
worked towards bringing best talented skilled workforce in biological laboratories and
agricultural chemical businesses, for new medicines with best valuable resources. Further
business strategies will be analysed by using porter 5 forces model (Top 5 Strategic Planning
Moves to Best Position Your Business for Success in 2020, 2019).
 Threat of substitutes: This force impact is low because AstraZeneca products,
medicines and drugs are unique in itself because of best quality standards and high
scale functional innovation developed. Company has been excelling towards bringing
best parameters within its pharmaceutical industry, for functional growth factors and
technical innovation towards drugs production with effective new scale trained
expertise.